Recurrent	B:C0026882
noncoding	I:C0026882
regulatory	I:C0026882
mutations	I:C0026882
in	O
pancreatic	O
ductal	I:C1335302
adenocarcinoma	I:C1335302
.	O

Recurrent	O
noncoding	I:C0026882
regulatory	I:C0026882
mutations	I:C0026882
in	O
pancreatic	B:C1335302
ductal	I:C1335302
adenocarcinoma	I:C1335302
.	O

The	O
contributions	O
of	O
coding	B:C0026882
mutations	I:C0026882
to	O
tumorigenesis	O
are	O
relatively	O
well	O
known	O
;	O
however	O
,	O
little	O
is	O
known	O
about	O
somatic	O
alterations	I:C0544886
in	O
noncoding	O
DNA	I:C0021920
.	O

The	O
contributions	O
of	O
coding	O
mutations	I:C0026882
to	O
tumorigenesis	B:C0007621
are	O
relatively	O
well	O
known	O
;	O
however	O
,	O
little	O
is	O
known	O
about	O
somatic	O
alterations	I:C0544886
in	O
noncoding	O
DNA	I:C0021920
.	O

The	O
contributions	O
of	O
coding	O
mutations	I:C0026882
to	O
tumorigenesis	O
are	O
relatively	O
well	O
known	O
;	O
however	O
,	O
little	O
is	O
known	O
about	O
somatic	B:C0544886
alterations	I:C0544886
in	O
noncoding	O
DNA	I:C0021920
.	O

The	O
contributions	O
of	O
coding	O
mutations	I:C0026882
to	O
tumorigenesis	O
are	O
relatively	O
well	O
known	O
;	O
however	O
,	O
little	O
is	O
known	O
about	O
somatic	O
alterations	I:C0544886
in	O
noncoding	B:C0021920
DNA	I:C0021920
.	O

Here	O
we	O
describe	O
GECCO	O
(	O
Genomic	O
Enrichment	O
Computational	O
Clustering	O
Operation	O
)	O
to	O
analyze	O
somatic	B:C0544886
noncoding	I:C0544886
alterations	I:C0544886
in	O
308	O
pancreatic	O
ductal	I:C1335302
adenocarcinomas	I:C1335302
(	O
pancreatic	O
ductal	I:C1335302
adenocarcinomas	I:C1335302
)	O
and	O
identify	O
commonly	O
mutated	O
regulatory	I:C0004793
regions	I:C0004793
.	O

Here	O
we	O
describe	O
GECCO	O
(	O
Genomic	O
Enrichment	O
Computational	O
Clustering	O
Operation	O
)	O
to	O
analyze	O
somatic	O
noncoding	I:C0544886
alterations	I:C0544886
in	O
308	O
pancreatic	B:C1335302
ductal	I:C1335302
adenocarcinomas	I:C1335302
(	O
pancreatic	O
ductal	I:C1335302
adenocarcinomas	I:C1335302
)	O
and	O
identify	O
commonly	O
mutated	O
regulatory	I:C0004793
regions	I:C0004793
.	O

Here	O
we	O
describe	O
GECCO	O
(	O
Genomic	O
Enrichment	O
Computational	O
Clustering	O
Operation	O
)	O
to	O
analyze	O
somatic	O
noncoding	I:C0544886
alterations	I:C0544886
in	O
308	O
pancreatic	O
ductal	I:C1335302
adenocarcinomas	I:C1335302
(	O
pancreatic	B:C1335302
ductal	I:C1335302
adenocarcinomas	I:C1335302
)	O
and	O
identify	O
commonly	O
mutated	O
regulatory	I:C0004793
regions	I:C0004793
.	O

Here	O
we	O
describe	O
GECCO	O
(	O
Genomic	O
Enrichment	O
Computational	O
Clustering	O
Operation	O
)	O
to	O
analyze	O
somatic	O
noncoding	I:C0544886
alterations	I:C0544886
in	O
308	O
pancreatic	O
ductal	I:C1335302
adenocarcinomas	I:C1335302
(	O
pancreatic	O
ductal	I:C1335302
adenocarcinomas	I:C1335302
)	O
and	O
identify	O
commonly	O
mutated	B:C0004793
regulatory	I:C0004793
regions	I:C0004793
.	O

We	O
find	O
recurrent	B:C0026882
noncoding	I:C0026882
mutations	I:C0026882
to	O
be	O
enriched	O
in	O
PDA	O
pathways	O
,	O
including	O
axon	O
guidance	I:C2984268
and	O
cell	O
adhesion	I:C0007577
,	O
and	O
newly	O
identified	O
processes	O
,	O
including	O
transcription	O
and	O
homeobox	O
genes	I:C0017347
.	O

We	O
find	O
recurrent	O
noncoding	I:C0026882
mutations	I:C0026882
to	O
be	O
enriched	O
in	O
PDA	B:C1335302
pathways	O
,	O
including	O
axon	O
guidance	I:C2984268
and	O
cell	O
adhesion	I:C0007577
,	O
and	O
newly	O
identified	O
processes	O
,	O
including	O
transcription	O
and	O
homeobox	O
genes	I:C0017347
.	O

We	O
find	O
recurrent	O
noncoding	I:C0026882
mutations	I:C0026882
to	O
be	O
enriched	O
in	O
PDA	O
pathways	B:C1704259
,	O
including	O
axon	O
guidance	I:C2984268
and	O
cell	O
adhesion	I:C0007577
,	O
and	O
newly	O
identified	O
processes	O
,	O
including	O
transcription	O
and	O
homeobox	O
genes	I:C0017347
.	O

We	O
find	O
recurrent	O
noncoding	I:C0026882
mutations	I:C0026882
to	O
be	O
enriched	O
in	O
PDA	O
pathways	O
,	O
including	O
axon	B:C2984268
guidance	I:C2984268
and	O
cell	O
adhesion	I:C0007577
,	O
and	O
newly	O
identified	O
processes	O
,	O
including	O
transcription	O
and	O
homeobox	O
genes	I:C0017347
.	O

We	O
find	O
recurrent	O
noncoding	I:C0026882
mutations	I:C0026882
to	O
be	O
enriched	O
in	O
PDA	O
pathways	O
,	O
including	O
axon	O
guidance	I:C2984268
and	O
cell	B:C0007577
adhesion	I:C0007577
,	O
and	O
newly	O
identified	O
processes	O
,	O
including	O
transcription	O
and	O
homeobox	O
genes	I:C0017347
.	O

We	O
find	O
recurrent	O
noncoding	I:C0026882
mutations	I:C0026882
to	O
be	O
enriched	O
in	O
PDA	O
pathways	O
,	O
including	O
axon	O
guidance	I:C2984268
and	O
cell	O
adhesion	I:C0007577
,	O
and	O
newly	O
identified	O
processes	O
,	O
including	O
transcription	B:C0040649
and	O
homeobox	O
genes	I:C0017347
.	O

We	O
find	O
recurrent	O
noncoding	I:C0026882
mutations	I:C0026882
to	O
be	O
enriched	O
in	O
PDA	O
pathways	O
,	O
including	O
axon	O
guidance	I:C2984268
and	O
cell	O
adhesion	I:C0007577
,	O
and	O
newly	O
identified	O
processes	O
,	O
including	O
transcription	O
and	O
homeobox	B:C0017347
genes	I:C0017347
.	O

We	O
identified	O
mutations	B:C0026882
in	O
protein	O
binding	I:C1514535
sites	I:C1514535
correlating	O
with	O
differential	O
expression	O
of	O
proximal	O
genes	O
and	O
experimentally	O
validated	O
effects	O
of	O
mutations	O
on	O
expression	O
.	O

We	O
identified	O
mutations	O
in	O
protein	B:C1514535
binding	I:C1514535
sites	I:C1514535
correlating	O
with	O
differential	O
expression	O
of	O
proximal	O
genes	O
and	O
experimentally	O
validated	O
effects	O
of	O
mutations	O
on	O
expression	O
.	O

We	O
identified	O
mutations	O
in	O
protein	O
binding	I:C1514535
sites	I:C1514535
correlating	O
with	O
differential	O
expression	B:C0017262
of	O
proximal	O
genes	O
and	O
experimentally	O
validated	O
effects	O
of	O
mutations	O
on	O
expression	O
.	O

We	O
identified	O
mutations	O
in	O
protein	O
binding	I:C1514535
sites	I:C1514535
correlating	O
with	O
differential	O
expression	O
of	O
proximal	B:C0205107
genes	O
and	O
experimentally	O
validated	O
effects	O
of	O
mutations	O
on	O
expression	O
.	O

We	O
identified	O
mutations	O
in	O
protein	O
binding	I:C1514535
sites	I:C1514535
correlating	O
with	O
differential	O
expression	O
of	O
proximal	O
genes	B:C0017337
and	O
experimentally	O
validated	O
effects	O
of	O
mutations	O
on	O
expression	O
.	O

We	O
identified	O
mutations	O
in	O
protein	O
binding	I:C1514535
sites	I:C1514535
correlating	O
with	O
differential	O
expression	O
of	O
proximal	O
genes	O
and	O
experimentally	O
validated	O
effects	O
of	O
mutations	B:C0026882
on	O
expression	O
.	O

We	O
identified	O
mutations	O
in	O
protein	O
binding	I:C1514535
sites	I:C1514535
correlating	O
with	O
differential	O
expression	O
of	O
proximal	O
genes	O
and	O
experimentally	O
validated	O
effects	O
of	O
mutations	O
on	O
expression	B:C0017262
.	O

We	O
developed	O
an	O
expression	O
modulation	O
score	O
that	O
quantifies	O
the	O
strength	O
of	O
gene	B:C0017263
regulation	I:C0017263
imposed	O
by	O
each	O
class	O
of	O
regulatory	O
elements	I:C0017362
,	O
and	O
found	O
the	O
strongest	O
elements	O
were	O
most	O
frequently	O
mutated	O
,	O
suggesting	O
a	O
selective	O
advantage	O
.	O

We	O
developed	O
an	O
expression	O
modulation	O
score	O
that	O
quantifies	O
the	O
strength	O
of	O
gene	O
regulation	I:C0017263
imposed	O
by	O
each	O
class	O
of	O
regulatory	B:C0017362
elements	I:C0017362
,	O
and	O
found	O
the	O
strongest	O
elements	O
were	O
most	O
frequently	O
mutated	O
,	O
suggesting	O
a	O
selective	O
advantage	O
.	O

We	O
developed	O
an	O
expression	O
modulation	O
score	O
that	O
quantifies	O
the	O
strength	O
of	O
gene	O
regulation	I:C0017263
imposed	O
by	O
each	O
class	O
of	O
regulatory	O
elements	I:C0017362
,	O
and	O
found	O
the	O
strongest	O
elements	B:C0017362
were	O
most	O
frequently	O
mutated	O
,	O
suggesting	O
a	O
selective	O
advantage	O
.	O

Our	O
detailed	O
single	B:C0022885
-	I:C0022885
cancer	I:C0022885
analysis	I:C0022885
of	O
noncoding	O
alterations	I:C0026882
identifies	O
regulatory	O
mutations	I:C0026882
as	O
candidates	O
for	O
diagnostic	O
and	O
prognostic	O
markers	O
,	O
and	O
suggests	O
new	O
mechanisms	O
for	O
tumor	O
evolution	I:C0007621
.	O

Our	O
detailed	O
single	O
-	I:C0022885
cancer	I:C0022885
analysis	I:C0022885
of	O
noncoding	B:C0026882
alterations	I:C0026882
identifies	O
regulatory	O
mutations	I:C0026882
as	O
candidates	O
for	O
diagnostic	O
and	O
prognostic	O
markers	O
,	O
and	O
suggests	O
new	O
mechanisms	O
for	O
tumor	O
evolution	I:C0007621
.	O

Our	O
detailed	O
single	O
-	I:C0022885
cancer	I:C0022885
analysis	I:C0022885
of	O
noncoding	O
alterations	I:C0026882
identifies	O
regulatory	B:C0026882
mutations	I:C0026882
as	O
candidates	O
for	O
diagnostic	O
and	O
prognostic	O
markers	O
,	O
and	O
suggests	O
new	O
mechanisms	O
for	O
tumor	O
evolution	I:C0007621
.	O

Our	O
detailed	O
single	O
-	I:C0022885
cancer	I:C0022885
analysis	I:C0022885
of	O
noncoding	O
alterations	I:C0026882
identifies	O
regulatory	O
mutations	I:C0026882
as	O
candidates	O
for	O
diagnostic	B:C1511876
and	O
prognostic	O
markers	O
,	O
and	O
suggests	O
new	O
mechanisms	O
for	O
tumor	O
evolution	I:C0007621
.	O

Our	O
detailed	O
single	O
-	I:C0022885
cancer	I:C0022885
analysis	I:C0022885
of	O
noncoding	O
alterations	I:C0026882
identifies	O
regulatory	O
mutations	I:C0026882
as	O
candidates	O
for	O
diagnostic	O
and	O
prognostic	O
markers	O
,	O
and	O
suggests	O
new	O
mechanisms	O
for	O
tumor	B:C0007621
evolution	I:C0007621
.	O

